Joliet Oncology & Hematology is categorized under Hematologists in Bolingbrook, IL .
Joliet Oncology & Hematology was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sarode Pundaleeka at the company’s single location by writing to 420 Remington Boulevard # 230, Bolingbrook, Illinois IL 60440 or by phoning (630) 759-7519. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Joliet Oncology & Hematology |
| Contact Person: | Sarode Pundaleeka |
| Address: | 420 Remington Boulevard # 230, Bolingbrook, Illinois 60440 |
| Phone Number: | (630) 759-7519 |
| Website Address: | jolietoncology.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Joliet Oncology & Hematology was started in 0 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sarode Pundaleeka for inquiries that concern Joliet Oncology & Hematology by calling the company number (630) 759-7519, as your correspondence is most welcome. Additionally, the physical location of the single location of Joliet Oncology & Hematology can be found at the coordinates 41.68215,-88.08542 as well as the street address 420 Remington Boulevard # 230 in Bolingbrook, Illinois 60440.
For its online presence, you may visit Joliet Oncology & Hematology’s website at jolietoncology.com and engage with its social media outlets through on Twitter and on Facebook.